McCauley, R., Zhang, A., Kota, V., Boccucci, J., Grunwald, M., Ulrickson, M., … Muffly, L. (2025). CRS/ICANS Prophylaxis does not Improve Outcomes in adult patients with Relapsed/Refractory B-cell acute lymphoblastic leukemia (B-ALL) treated with brexucabtagene autoleucel. In Blood (Vol. 146, pp. 2396–2396). American Society of Hematology. https://doi.org/10.1182/blood-2025-2396

McCauley, Ross, Amy Zhang, Vamsi Kota, Jacob Boccucci, Michael Grunwald, Matthew Ulrickson, LaQuisa Hill, et al. “CRS/ICANS Prophylaxis does not Improve Outcomes in adult patients with Relapsed/Refractory B-cell acute lymphoblastic leukemia (B-ALL) treated with brexucabtagene autoleucel.” In Blood, 146:2396–2396. American Society of Hematology, 2025. https://doi.org/10.1182/blood-2025-2396.

McCauley R, Zhang A, Kota V, Boccucci J, Grunwald M, Ulrickson M, et al. CRS/ICANS Prophylaxis does not Improve Outcomes in adult patients with Relapsed/Refractory B-cell acute lymphoblastic leukemia (B-ALL) treated with brexucabtagene autoleucel. In: Blood. American Society of Hematology; 2025. p. 2396–2396.

McCauley, Ross, et al. “CRS/ICANS Prophylaxis does not Improve Outcomes in adult patients with Relapsed/Refractory B-cell acute lymphoblastic leukemia (B-ALL) treated with brexucabtagene autoleucel.” Blood, vol. 146, no. Supplement 1, American Society of Hematology, 2025, pp. 2396–2396. Crossref, doi:10.1182/blood-2025-2396.

McCauley R, Zhang A, Kota V, Boccucci J, Grunwald M, Ulrickson M, Hill L, Muhsen I, Sasine J, Advani A, Aldoss I, Sandhu K, Reshef R, Luskin M, Lin C, Cassaday R, Kopmar N, Solh M, Odstrcil Bobillo S, Tsai S, Hilal T, Shah B, Faramand R, Park J, Valtis Y, Othman T, Vasu S, Bezerra E, Leonard J, Tan V, O’Dwyer K, Moore J, Jamy O, Mohty R, Kumaran M, Hoeg R, Stock W, Oliai C, Lill G, Schwartz M, Koura D, Dykes K, Logan A, Daunov M, Byrd K, Yalniz F, Frey N, Connor M, Yaghmour G, Irizarry Gatell V, Jackson C, Oluwole O, Al-Darobi A, Chen E, Lee C, O’Connor T, Dholaria B, Bachanova V, Tracy S, Srinagesh H, Miller K, Sutherland K, Majhail N, Mountjoy L, Malik S, Ramakrishnan A, Shaughnessy P, Mathews J, Wang E, Battiwalla M, Roloff G, Muffly L. CRS/ICANS Prophylaxis does not Improve Outcomes in adult patients with Relapsed/Refractory B-cell acute lymphoblastic leukemia (B-ALL) treated with brexucabtagene autoleucel. Blood. American Society of Hematology; 2025. p. 2396–2396.